Making Sense of Allergic Rhinitis: Key Points in Optimizing Patient Counseling Strategies

Thom Kim Nguyen, PharmD, BCPS
Published Online: Monday, March 17, 2014
Follow Pharmacy_Times:
This activity is supported by an educational grant from Chattem, Inc.

Making Sense of Allergic Rhinitis: Key Points in Optimizing Patient Counseling Strategies

Thom Kim Nguyen, PharmD, BCPS
Clinical Assistant Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Ambulatory Care Clinical Pharmacist
Hunterdon Medical Center
Flemington, New Jersey

Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose.

Faculty
Thom Kim Nguyen, PharmD, BCPS

Pharmacy Times Office of Continuing Professional Education
Planning StaffDavid Heckard; Maryjo Dixon, RPh; Steve Lin, PharmD, RPh; and Donna Fausak

Pharmacy Times
Editorial StaffBea Riemschneider and Kirk McKay

An anonymous peer reviewer is used as part of content validation and conflict resolution.
The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Objective
After participating in this activity, participants should be able to:
  • Apply counseling strategies to help address common patient questions to achieve optimal symptom relief in allergic rhinitis.
Target audience: Pharmacists
Type of activity: Knowledge
Release date: March 12, 2014
Expiration date: March 12, 2016
Estimated time to complete activity: 2 hours
Fee: Free

Click here to view this activity.
 
Description: Pharmacy Times/Ascend Media Office of Continuing Professional EducationPharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.1 CEUs) under the ACPE universal activity number 0290-0000-14-016-H01-P. The activity is available for CE credit through March 12, 2016.

Related Articles
Rhinovirus infection tends to aggravate other conditions in the elderly.
Wockhardt USA LLC introduces its newest private label, OTC medication Fexofenadine in a small, easy-to-swallow tablet for next year’s fall allergy season.
A new FDA approval may soon help children with allergies seek relief from nasal symptoms.
The majority of patients who require inhalers for asthma or epinephrine autoinjectors for allergic disease for do not use the devices properly.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$